marijuana stocks news

Colorado’s Largest Licensed Cannabis and Microbiological Testing Laboratory: Ready to Assist the Cannabis Industry Respond to Recent Med Rulings on Harmful Contaminates

DENVER, CO / ACCESSWIRE / October 9, 2014 / CannLabs, Inc. (CANL), a leader in cannabis testing, formulation, innovation and consultation today announced it was launching their microbial contaminate testing and consultative service in response to recent Colorado Marijuana Enforcement Division (MED) rulings. The expanded testing service will allow growers to test their products for microbial contamination, residual solvents and screen for pesticides. CannLabs provides consulting services to help growers remediate their products should test results not meet current MED microbial testing standards. Until the beta test begins, now scheduled for mid-November, results below the MED standard do not have to be reported.

“This is a great opportunity for growers to ensure that their valuable production meet public health and safety standards by using our contamination testing services,” said Mark Mirken, Chief Executive Officer of CannLabs. “As Colorado’s largest licensed cannabis and microbiological testing laboratory, CannLabs is uniquely positioned to provide a consultative approach to help growers due to our microbiology expertise, real-time data analytics, and proprietary technology.” Mirken added “Our goal is to ensure we are continuously aligned with our partners’ testing and consulting needs to provide immediate solutions to help them avoid a potentially catastrophic financial loss.”

Future regulatory requirements for marijuana, announced by the state of Colorado, include mandatory random testing for contaminants such as Salmonella, E.coli, mold, mildew and fungus will begin in mid-November. The latest testing requirements are in addition to the current regulations around potency testing for flower, concentrates and edibles. Once the MED implements the random beta testing program, any contaminated product identified will have the opportunity to be remediated or it will not be able to be commercialized.

ABOUT CANNLABS

CannLabs, Inc., serves the cannabis industry with proprietary cloud-based analytics and scientific methods. It has served as a respected authority and advisor to various government, educational, and commercial interests regarding this growing business segment. Through Carbon Bond Holdings Inc., CannLabs provides laboratories with the necessary business intelligence and technology required to serve the cannabis industry. This includes the first state-certified cannabis testing laboratory in the country located in Denver, Colorado.

CannLabs enables growers, dispensaries and edible makers to implement best practices and product advancements. In addition, the CannLabs website allows consumers to easily locate certified tested products to meet their specific needs.

CannLabs has been at the forefront of educating the public, and serving as a reliable information resource to state and local governments as more states legalize marijuana for various uses. The Company provides client education to ensure safe cultivation and identify contamination problems. Additionally, CannLabs consults on legal cases and the reformulation of cannabis products throughout the U.S. and Canada.

For more information visit www.cannlabs.com.

Safe Harbor Statement

All statements herein other than statements of historical facts are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Such statements are not guarantees of future performance and are subject to known and unknown risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements. Such factors include, but are not limited to, our ability to raise additional capital, our limited operating history and revenue, our ability to attract and retain qualified personnel, our ability to develop new services, market acceptance of our services, legislative, regulatory and competitive developments in our industry, general economic conditions, as well as other factors set forth in our filings with the SEC.

CONTACT:

Company

William Livermore

Public Relations

917-620-0774

william.livermore@cannlabs.com

www.cannlabs.com

Investor Relations

Matthew Selinger

Senior Vice President – MZ North America

415-572-8152

mselinger@mzgroup.us

www.mzgroup.us

SOURCE: CannLabs, Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Neptune Wellness Solutions Inc. (NEPT) Announces Closing of Debt Financing

Neptune Announces Closing of Debt Financing Neptune Wellness Solutions Inc. (“Neptune” or…

Innovative Industrial Properties, Inc. (IIPR) Properties Declares Second Quarter 2020 Dividends

Innovative Industrial Properties Declares Second Quarter 2020 Dividends Innovative Industrial Properties, Inc.…

Tetra Bio-Pharma Inc. (TBPMF) Receives FDA Orphan Drug Designation for its Ophthalmic Clinical Program

Tetra Receives FDA Orphan Drug Designation for its Ophthalmic Clinical Program  …

Medical Marijuana, Inc. (MJNA) Appoints Squar Milner LLP as New Independent Auditor

Medical Marijuana, Inc. Appoints Squar Milner LLP as New Independent Auditor Medical…